Institution of Chemical Engineers

AIChE and IChemE Announce Webinar Series and Annual Conference to Advance Hydrogen as an Energy Carrier

Retrieved on: 
Monday, March 11, 2024
Hydrogen, Transport, Government, Institution of Chemical Engineers, Conference, Hydrogen technologies, Organization, Chemical engineering, American Institute, GHG, Partnership, Renewable energy

The webinar series will launch in the second quarter of 2024, and will include contributions from AIChE and IChemE.

Key Points: 
  • The webinar series will launch in the second quarter of 2024, and will include contributions from AIChE and IChemE.
  • Among the first offerings will be a session that considers “myths and realities” related to hydrogen and its use.
  • In 2025, the organizations will debut a joint annual conference focusing on the production and use of hydrogen.
  • The 2025 Hydrogen Technologies and Applications Conference will be held in North America, with the 2026 Conference being scheduled to take place in the UK.

Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors

Retrieved on: 
Wednesday, November 15, 2023
Aston, Engineering physics, NYSE, NMT, Francis Crick Institute, AstraZeneca, Spacecraft, Therapy, Biology, ADC, CSO, Patient, Sofinnova, MedImmune, Chemical engineering, Chris, Aston University, MBA, Drug discovery, University, Cancer, Imperial College London, IMD, Institution of Chemical Engineers, Knowledge, New York Stock Exchange, Fine chemical, Pharmaceutical industry

Dr Martin is a renowned biotech company founder, director and entrepreneur, and a pioneer and leader in the ADC space.

Key Points: 
  • Dr Martin is a renowned biotech company founder, director and entrepreneur, and a pioneer and leader in the ADC space.
  • Dr Martin was instrumental in co-founding ADC Therapeutics (NYSE: ADCT) in Jan 2012 and served as its CEO since inception until May 2022.
  • Alongside his role as Chairman of Myricx, he is also Chairman of the Board of Tokamak Energy Ltd, and Tagworks Pharmaceuticals BV, and a Director on the Board of Osivax SAS.
  • Dr Robin Carr, Myricx CEO and Board Director, said, “We are thrilled that Chris has joined our Board and taken on the role of Chairman.

Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Officer

Retrieved on: 
Tuesday, December 12, 2023
Health, Genetics, Other Health, Research, Science, Pharmaceutical, Biotechnology, Quell, Therapy, CFO, Chemical engineering, Huber loss, MPD, CMC, Retirement, Institution of Chemical Engineers, Pharmaceutical industry, Chemistry

Bernd Schmidt previously worked at Quell Therapeutics where he served as Vice President Product Delivery.

Key Points: 
  • Bernd Schmidt previously worked at Quell Therapeutics where he served as Vice President Product Delivery.
  • Nawal Ouzren, Chief Executive Officer of Sensorion, said: “I am thrilled to welcome Bernd Schmidt to Sensorion as our new CTO.
  • I would like to congratulate Bernd in his new role and welcome in our team.”
    Bernd Schmidt, Chief Technical Officer of Sensorion, commented: “I am looking forward to joining a company with such a pioneering and visionary approach in the complex gene therapy field.
  • Sensorion wishes David well in his retirement and thanks him for his contribution.

Cameco Announces Third Quarter Results; Tier-One Transition Continues to Drive Gross Profit Improvement; Amplified Security of Supply Concerns Benefit Full-Year Revenue Outlook; Decade-High Industry Contracting Volume Achieved; Dividend Declared

Retrieved on: 
Tuesday, October 31, 2023
Chemicals, Plastics, Mining, Minerals, Manufacturing, Energy, Natural Resources, Nuclear, Caspian, Transfer, JV, Canada Revenue Agency, United Kingdom, Brookfield Renewable Partners, NYSE, International, Health, Uranium, WNA, Government, Canadian Nuclear Safety Commission, University, CCO, Acquisition, International Financial Reporting Standards, Babcock International, MBA, Urenco Group, Nuclear energy, Engineering, Institution of Chemical Engineers, International Atomic Energy Agency, Environment, Growth, World Nuclear Association, Transport, Risk, Turkish coup d'état, Tax court, Henley Business School, Safety, McArthur, Chief commercial officer, CRA, Henley Business School South Africa, TSX, Renewable energy, Uranium mining, Bank, Rare-earth element, Westinghouse, Kazatomprom, Cameco, McArthur River, Energoatom, Inkai Uranium Project

In the short term, supply chain issues and inflation risks are causing production challenges for current operators.

Key Points: 
  • In the short term, supply chain issues and inflation risks are causing production challenges for current operators.
  • Compared to previous price cycles, the market does not have the inventory or secondary supplies to absorb market shocks.
  • This conference of government and industry leaders met with the intention of building leadership and cooperation in nuclear energy.
  • The transition to a clean and secure energy world is our imperative and I look forward to helping this transition with Cameco,” said Dominic Kieran.

Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate "Programmable Drug Delivery" for RNA and Gene Therapies

Retrieved on: 
Tuesday, October 10, 2023
Nanomedicine, Data science, Doctor of Philosophy, Machine learning, Vaccine, Yogev, TEL, RNA, LNP, EBay, AI, MD, Organization, Therapy, Cardiology, Neurology, Twist, Wolf Foundation, Cystic fibrosis, Health, Department of Chemical Engineering, Imperial College London, Biotechnology, Medicine, General partnership, Beam Therapeutics, R, Artificial intelligence, Twist Bioscience, Bayer, MIT, CRISPR, Conditional sentence, Chemical engineering, Compiler, Chemical substance, Gene editing, MIT Technology Review, IPO, Tissue, Rising Star, Institution of Chemical Engineers, Nanotechnology, Young Innovation Leaders Fellowship, Pharmaceutical industry, Biogen, Pfizer, Technion – Israel Institute of Technology

Mana.bio's integrated experimental and machine learning platform enables the discovery of smarter, faster, more precise delivery formulations to unlock the field of nucleic acid-based and genetic medicines.

Key Points: 
  • Mana.bio's integrated experimental and machine learning platform enables the discovery of smarter, faster, more precise delivery formulations to unlock the field of nucleic acid-based and genetic medicines.
  • We are encouraged by our platform's early in vivo success and for its potential to deliver breakthrough therapies for a broad range of diseases."
  • RNA-based therapies and genetic medicines offer immense potential to transform approaches to vaccines, gene editing, gene therapy and more.
  • The limitations on delivery methods have severely restricted the full therapeutic promise of RNA, CRISPR and gene therapies.

enfinium appoints Dr Jane Atkinson CBE as Chief Operating Officer

Retrieved on: 
Wednesday, November 16, 2022
Chemical engineering, Automation, Ferrybridge, First Sentier Investors, Igneo, Bilfinger, Royal Academy of Arts, ESG, Institution of Chemical Engineers, Leadership, Workforce, Industry, Institute, Waste management, Trustee, Royal Academy of Engineering, CBE, Birthday, Management, Renewable energy, Engineering, British Steel

LONDON, Nov. 16, 2022 /PRNewswire/ -- enfinium is pleased to announce the appointment of Dr Jane Atkinson CBE, former Engineering and Automation Executive Director at Bilfinger, as the new Chief Operating Officer.

Key Points: 
  • LONDON, Nov. 16, 2022 /PRNewswire/ -- enfinium is pleased to announce the appointment of Dr Jane Atkinson CBE, former Engineering and Automation Executive Director at Bilfinger, as the new Chief Operating Officer.
  • Dr Atkinson brings over 30 years of senior leadership experience with a diverse background in engineering, plant management and operations.
  • Dr Atkinson will begin working through a planned succession and detailed handover process with William (Bill) Roberts, the current Chief Operating Officer, who will be retiring in 2023, ensuring a smooth transition.
  • Dr Jane Atkinson CBE said, "I am thrilled to be joining enfinium at an important time in its growth strategy.

Evox Therapeutics Appoints Peter Jones as Vice President of CMC

Retrieved on: 
Thursday, April 14, 2022
Aston, Process, Engineering, Hertfordshire, Chemical engineering, GlaxoSmithKline, Orchard, Biology, Royal Academy of Arts, Royal Academy of Engineering, Oxford BioMedica, Master of Science, API, Central nervous system, Brain, GLOBE, Biochemical engineering, Patient, Cell, Tissue, Institution of Chemical Engineers, Technology, Lego Star Wars: The Complete Saga, CAR, CD19, University of Hertfordshire, CMC, University college, Bachelor of Science, Exosome, Oxford, Antibody, University, Aston University, Health, Seminal vesicles, Therapy, Pharmaceutical industry, Fine chemical, Genzyme, Discovery

OXFORD, United Kingdom, April 14, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (Evox or the Company), a leading exosome therapeutics company, announces the appointment of Peter Jones as Vice President of CMC.

Key Points: 
  • OXFORD, United Kingdom, April 14, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (Evox or the Company), a leading exosome therapeutics company, announces the appointment of Peter Jones as Vice President of CMC.
  • Mr. Jones has more than 30 years of process development experience in the biopharmaceutical industry, building and leading cross-functional teams to support clinical and commercial development.
  • Before joining Evox, he was Executive Director, Process Development at Autolus Therapeutics plc, where he led late-stage CMC activities for the AUTO1 (obe-cel) CD19 CAR T cell therapy program.
  • Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics.

University of Nottingham Ningbo China’s Chemical and Environmental Engineering Programmes Lead the Way for Future Careers in Sustainable Development

Retrieved on: 
Friday, April 8, 2022
Education, Engineering, Environment, Manufacturing, Other Science, Science, University, Tao, Morgan Stanley, UNNC, Faculty, First Nations in Ontario, Engineering, Chemical engineering, University, Parent, UNEP, Goal, Research, School, Environment, Environmental engineering, Employment, Government, University of Manchester Faculty of Science and Engineering, Industry, Institute, Mineral resource classification, United Nations, Institute of Materials, Minerals and Mining, Institution of Chemical Engineers, Chemistry, Student, Mineral, University of Nottingham Ningbo China, ExxonMobil, Biophysical environment, Medicine, Science, Mining

The University of Nottingham Ningbo China (UNNC)s School of Chemical and Environmental Engineering has received multiple international accreditations, including by the Institute of Materials, Minerals and Mining (IoM3) and the Institution of Chemical Engineers (IChemE).

Key Points: 
  • The University of Nottingham Ningbo China (UNNC)s School of Chemical and Environmental Engineering has received multiple international accreditations, including by the Institute of Materials, Minerals and Mining (IoM3) and the Institution of Chemical Engineers (IChemE).
  • In addition, the School also has excellent and experienced teaching fellows and receives regular glowing reviews from its international student body.
  • In recent years, courses related to the disciplines of chemistry and environmental studies have become increasingly popular with students and parents.
  • In the view of Professor Tao Wu, Dean of the Faculty of Science and Engineering at UNNC, the two undergraduate courses of UNNC Chemical Engineering and Environmental Engineering have great potential.

MicroSilicon Innovation Gains International Recognition

Retrieved on: 
Tuesday, November 9, 2021
Rice University, Technology, Research, Abu Dhabi National Oil Company, Oil, Award, Institution of Chemical Engineers, ADNOC, Risk, Quantum, Medical imaging

HOUSTON, Nov. 8, 2021 /PRNewswire-PRWeb/ --MicroSilicon announced today that one of its joint research projects received international recognition at the IChemE Global Awards Event in October 2021.

Key Points: 
  • HOUSTON, Nov. 8, 2021 /PRNewswire-PRWeb/ --MicroSilicon announced today that one of its joint research projects received international recognition at the IChemE Global Awards Event in October 2021.
  • The winning project was a joint submission between Abu Dhabi National Oil Company (ADNOC) and Microsilicon that had been initiated by ADNOC and Rice University, Texas, and which was subsequently spun-off to launch the MicroSilicon company.
  • MicroSilicon built on the original idea of real-time asphaltene monitoring to create the Quantum-RF* System.
  • The Quantum-RF System itself has already received international recognition, including being nominated for Best Digital Transformation Technology at 2018 World Oil Awards ceremony.

Fluor Selected as Global Award 2019 Finalist by The Institution of Chemical Engineers

Retrieved on: 
Monday, October 14, 2019
Oil, Gas, Manufacturing, Energy, Engineering, Chemicals, Plastics, Fluor Corporation, Petroleum engineering, FLR, Institution of Chemical Engineers, Fluor, New York Stock Exchange, Economy of the United States, Companies, Industries

Fluor Corporation (NYSE: FLR) announced today that it has been named as a finalist in three categories including oil and gas, research project, and diversity and inclusion for the Institution of Chemical Engineers (IChemE) Global 2019 Awards .

Key Points: 
  • Fluor Corporation (NYSE: FLR) announced today that it has been named as a finalist in three categories including oil and gas, research project, and diversity and inclusion for the Institution of Chemical Engineers (IChemE) Global 2019 Awards .
  • Winners will be announced at an awards event being held in the UK on November 7, 2019.
  • We are proud to be finalists with some top leading companies and wish everyone good luck at the awards.
  • Founded in 1912, Fluor Corporation (NYSE: FLR) is a global engineering, procurement, fabrication, construction and maintenance company that transforms the world by building prosperity and empowering progress.